These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 26634305

  • 1. Clinical importance of faecal calprotectin variability in inflammatory bowel disease: intra-individual variability and standardisation of sampling procedure.
    Kristensen V, Malmstrøm GH, Skar V, Røseth A, Moum B.
    Scand J Gastroenterol; 2016; 51(5):548-55. PubMed ID: 26634305
    [Abstract] [Full Text] [Related]

  • 2. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis.
    Lasson A, Stotzer PO, Öhman L, Isaksson S, Sapnara M, Strid H.
    J Crohns Colitis; 2015 Jan; 9(1):26-32. PubMed ID: 25008478
    [Abstract] [Full Text] [Related]

  • 3. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
    Kristensen V, Lauritzen T, Jelsness-JØrgensen LP, Moum B.
    Scand J Clin Lab Invest; 2015 Sep; 75(5):355-61. PubMed ID: 25856663
    [Abstract] [Full Text] [Related]

  • 4. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 5. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 6. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
    Kristensen V, Klepp P, Cvancarova M, Røseth A, Skar V, Moum B.
    J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
    [Abstract] [Full Text] [Related]

  • 7. Faecal chitinase 3-like 1 is a reliable marker as accurate as faecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases.
    Buisson A, Vazeille E, Minet-Quinard R, Goutte M, Bouvier D, Goutorbe F, Pereira B, Barnich N, Bommelaer G.
    Aliment Pharmacol Ther; 2016 May; 43(10):1069-79. PubMed ID: 26953251
    [Abstract] [Full Text] [Related]

  • 8. Clinical implications of assay specific differences in f-calprotectin when monitoring inflammatory bowel disease activity over time.
    Amcoff K, Stridsberg M, Lampinen M, Magnuson A, Carlson M, Halfvarson J.
    Scand J Gastroenterol; 2017 Mar; 52(3):344-350. PubMed ID: 27881032
    [Abstract] [Full Text] [Related]

  • 9. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M, Trouvé C, Baert F, De Smet D, Langlois M, Vanpoucke H.
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [Abstract] [Full Text] [Related]

  • 10. Low fecal calprotectin predicts sustained clinical remission in inflammatory bowel disease patients: a plea for deep remission.
    Mooiweer E, Severs M, Schipper ME, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    J Crohns Colitis; 2015 Jan; 9(1):50-5. PubMed ID: 25518048
    [Abstract] [Full Text] [Related]

  • 11. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children.
    Sandhu K, Naik S, Ayling RM.
    Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889
    [Abstract] [Full Text] [Related]

  • 12. Faecal calprotectin: a marker of inflammation throughout the intestinal tract.
    Summerton CB, Longlands MG, Wiener K, Shreeve DR.
    Eur J Gastroenterol Hepatol; 2002 Aug; 14(8):841-5. PubMed ID: 12172403
    [Abstract] [Full Text] [Related]

  • 13. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    Whitehead SJ, Ford C, Gama RM, Ali A, McKaig B, Waldron JL, Steed H, Brookes MJ.
    J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301
    [Abstract] [Full Text] [Related]

  • 14. Patient-performed extraction of faecal calprotectin.
    Kristensen V, Lauritzen T, Jelsness-Jørgensen LP, Frigstad SO, Corwin C, Moum B.
    Clin Chem Lab Med; 2016 Aug 01; 54(8):1357-63. PubMed ID: 26812797
    [Abstract] [Full Text] [Related]

  • 15. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.
    Inflamm Bowel Dis; 2014 Feb 01; 20(2):307-14. PubMed ID: 24374878
    [Abstract] [Full Text] [Related]

  • 16. Variability of Faecal Calprotectin in Inflammatory Bowel Disease Patients: An Observational Case-control Study.
    Cremer A, Ku J, Amininejad L, Bouvry MR, Brohet F, Liefferinckx C, Devière J, van Gossum A, Smet J, Stordeur P, Franchimont D.
    J Crohns Colitis; 2019 Oct 28; 13(11):1372-1379. PubMed ID: 30944925
    [Abstract] [Full Text] [Related]

  • 17. Agreement Between Home-Based Measurement of Stool Calprotectin and ELISA Results for Monitoring Inflammatory Bowel Disease Activity.
    Heida A, Knol M, Kobold AM, Bootsman J, Dijkstra G, van Rheenen PF.
    Clin Gastroenterol Hepatol; 2017 Nov 28; 15(11):1742-1749.e2. PubMed ID: 28606846
    [Abstract] [Full Text] [Related]

  • 18. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan 28; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 19. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
    Lee YW, Lee KM, Lee JM, Chung YY, Kim DB, Kim YJ, Chung WC, Paik CN.
    Korean J Intern Med; 2019 Jan 28; 34(1):72-80. PubMed ID: 29347813
    [Abstract] [Full Text] [Related]

  • 20. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E, Beglinger C.
    Swiss Med Wkly; 2012 Jan 28; 142():w13557. PubMed ID: 22481443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.